Egberts, F., Gutzmer, R., Ugurel, S., Becker, J. C., Trefzer, U., Degen, A., . . . Hauschild, A. (2011). Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: A multicenter phase II DeCOG trial. Annals of oncology, 22(7), . https://doi.org/10.1093/annonc/mdq648
Chicago-Zitierstil (17. Ausg.)Egberts, Friederike, et al. "Sorafenib and Pegylated Interferon-α2b in Advanced Metastatic Melanoma: A Multicenter Phase II DeCOG Trial." Annals of Oncology 22, no. 7 (2011). https://doi.org/10.1093/annonc/mdq648.
MLA-Zitierstil (9. Ausg.)Egberts, Friederike, et al. "Sorafenib and Pegylated Interferon-α2b in Advanced Metastatic Melanoma: A Multicenter Phase II DeCOG Trial." Annals of Oncology, vol. 22, no. 7, 2011, https://doi.org/10.1093/annonc/mdq648.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.